Jeffrey M. Jonas's most recent trade in Compass Pathways Plc - ADR was a trade of 52,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Pathways PLC (ADR) | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2025 | 52,000 | 52,000 | - | - | Share Option (Right to Buy) | |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 13,810 | 33,702 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 01 Aug 2023 | 13,810 | 14,800 (0%) | 0% | 7.3 | 100,399 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 195.61 per share. | 01 Aug 2023 | 6,301 | 5,100 (0%) | 0% | 195.6 | 1,232,539 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 194.78 per share. | 01 Aug 2023 | 3,399 | 11,401 (0%) | 0% | 194.8 | 662,057 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 196.59 per share. | 01 Aug 2023 | 3,110 | 1,990 (0%) | 0% | 196.6 | 611,395 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 198.41 per share. | 01 Aug 2023 | 600 | 990 (0%) | 0% | 198.4 | 119,046 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 197.66 per share. | 01 Aug 2023 | 400 | 1,590 (0%) | 0% | 197.7 | 79,064 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 13,810 | 47,512 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 03 Jul 2023 | 13,810 | 14,800 (0%) | 0% | 7.3 | 100,399 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 215.91 per share. | 03 Jul 2023 | 7,966 | 6,600 (0%) | 0% | 215.9 | 1,719,939 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 216.78 per share. | 03 Jul 2023 | 3,201 | 3,399 (0%) | 0% | 216.8 | 693,913 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 217.82 per share. | 03 Jul 2023 | 2,409 | 990 (0%) | 0% | 217.8 | 524,728 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 214.61 per share. | 03 Jul 2023 | 234 | 14,566 (0%) | 0% | 214.6 | 50,219 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 1,904 | 1,904 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 990 | 990 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 10 Feb 2023 | 11,643 | 133,624 (0%) | 0% | 0.4 | 5,239 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 11,643 | 0 | - | - | Stock Options (Right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 44.47 per share. | 10 Feb 2023 | 7,805 | 125,819 (0%) | 0% | 44.5 | 347,084 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 44.90 per share. | 10 Feb 2023 | 3,838 | 121,981 (0%) | 0% | 44.9 | 172,329 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 5,100 | 123,408 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. | 03 Feb 2023 | 1,427 | 121,981 (0%) | 0% | 44.2 | 63,016 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 2,501 | 57,499 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.63 per share. | 03 Jan 2023 | 2,501 | 118,308 (0%) | 0% | 28.6 | 71,604 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,000 | 5,000 | - | - | Option (right to buy) | |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,200 | 19,200 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 30,944 | 11,643 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 27 Apr 2022 | 30,944 | 115,807 (0%) | 0% | 0.5 | 13,925 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 17 Feb 2022 | 4,000 | 84,863 (0%) | 0% | 0.5 | 1,800 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 4,000 | 42,587 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 10,000 | 85,237 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. | 19 Oct 2021 | 4,374 | 80,863 (0%) | 0% | 40.3 | 176,228 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 8,500 | 8,500 | - | - | Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 15 Jun 2021 | 12,000 | 75,237 (0%) | 0% | 0.5 | 5,400 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 12,000 | 46,587 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 10,000 | 66,330 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. | 15 Jun 2021 | 3,093 | 63,237 (0%) | 0% | 58.8 | 181,868 | Common Stock |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) |